Metraipolis › archive › dc_ff5b597fc299

Systemic and immunotoxicity induced by topical application of perfluoroheptane sulfonic acid (PFHpS) or perfluorooctane sulfonic acid (PFOS) in a murine model — Europe PMC PMID:39066581

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/39066581
DOI
10.1080/1547691x.2024.2371868
License (as archived)
CC0-1.0
Archived
2026-10-06T16:55:10.822Z
SHA-256 of the archived text
b19442f2033a8f688f474642d9341dc038fb1f64476efb2fd9f8e81270e7ee35
Stable URL of this page
https://metraipolis.com/documento/dc_ff5b597fc299

How to cite

Systemic and immunotoxicity induced by topical application of perfluoroheptane sulfonic acid (PFHpS) or perfluorooctane sulfonic acid (PFOS) in a murine model — Europe PMC PMID:39066581 — Europe PMC (en), https://europepmc.org/article/MED/39066581 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_ff5b597fc299 (Metraipolis archive dc_ff5b597fc299, sha256 b19442f2033a8f688f474642d9341dc038fb1f64476efb2fd9f8e81270e7ee35)
BibTeX
@misc{dcff5b597fc299,
  title = {Systemic and immunotoxicity induced by topical application of perfluoroheptane sulfonic acid (PFHpS) or perfluorooctane sulfonic acid (PFOS) in a murine model — Europe PMC PMID:39066581},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/39066581},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_ff5b597fc299; sha256 b19442f2033a8f688f474642d9341dc038fb1f64476efb2fd9f8e81270e7ee35},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/39066581. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Per- and polyfluoroalkyl substances (PFAS) are a large group of synthetic surfactants of over 12,000 compounds that are incorporated into numerous products for their chemical and physical properties. Studies have associated PFAS with adverse health effects. Although there is a high potential for dermal exposure, these studies are lacking. The present study evaluated the systemic and immunotoxicity of subchronic 28- or 10-days of dermal exposure, respectively, to PFHpS (0.3125-2.5% or 7.82-62.5 mg/kg/dose) or PFOS (0.5% or 12.5 mg/kg/dose) in a murine model. Elevated levels of PFHpS were detected in the serum and urine, suggesting that absorption is occurring through the dermal route. PFHpS induced significantly increased relative liver weight, significantly decreased relative spleen and thymus weight, altered serum chemistries, and altered histopathology. Additionally, PFHpS significantly reduced the humoral immune response and altered immune subsets in the spleen, suggesting immunosuppression. Gene expression changes were observed in the liver, skin, and spleen of genes involved in fatty acid metabolism, necrosis, and inflammation. Immune-cell phenotyping identified significant decreases in B-cells and CD11b + monocyte and/or macrophages in the spleen along with decreases in eosinophils and dendritic cells in the skin. These findings support PFHpS absorption through the skin leading to liver damage and immune suppression.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera).
Pubblicazione: Journal of immunotoxicology, 2024 (prima pubblicazione 2024-07-27).
Identificativi: PMID 39066581 · PMCID PMC11590111 · DOI 10.1080/1547691x.2024.2371868.
Parole chiave degli autori: Immune; Liver damage; PPAR; immunosuppression; Dermal; Perfluoroheptane Sulfonic Acid (Pfhps;), Toxicity.
Descrittori MeSH principali: Alkanesulfonic Acids; Fluorocarbons.
Pagina: https://europepmc.org/article/MED/39066581 — https://doi.org/10.1080/1547691x.2024.2371868. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-10-06T15:19:26.802Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.